Nyrada Yönetim

Yönetim kriter kontrolleri 3/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

James Bonnar

İcra Kurulu Başkanı

AU$354.3k

Toplam tazminat

CEO maaş yüzdesi	85.7%
CEO görev süresi	no data
CEO sahipliği	0.08%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	5.2yrs

Son yönetim güncellemeleri

Shareholders Will Probably Not Have Any Issues With Nyrada Inc.'s (ASX:NYR) CEO Compensation

Nov 12

Recent updates

Shareholders Will Probably Not Have Any Issues With Nyrada Inc.'s (ASX:NYR) CEO Compensation

Nov 12

Companies Like Nyrada (ASX:NYR) Can Afford To Invest In Growth

Jan 10

We're Keeping An Eye On Nyrada's (ASX:NYR) Cash Burn Rate

Feb 23

CEO Tazminat Analizi

James Bonnar'un ücretlendirmesi Nyrada'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	AU$354k	AU$304k	-AU$1m
Mar 31 2024	n/a	n/a	-AU$3m
Dec 31 2023	n/a	n/a	-AU$5m
Sep 30 2023	n/a	n/a	-AU$6m
Jun 30 2023	AU$394k	AU$294k	-AU$8m
Mar 31 2023	n/a	n/a	-AU$6m
Dec 31 2022	n/a	n/a	-AU$4m
Sep 30 2022	n/a	n/a	-AU$4m
Jun 30 2022	AU$464k	AU$274k	-AU$4m
Mar 31 2022	n/a	n/a	-AU$4m
Dec 31 2021	n/a	n/a	-AU$4m
Sep 30 2021	n/a	n/a	-AU$4m
Jun 30 2021	AU$378k	AU$277k	-AU$4m
Mar 31 2021	n/a	n/a	-AU$5m
Dec 31 2020	n/a	n/a	-AU$6m
Sep 30 2020	n/a	n/a	-AU$6m
Jun 30 2020	AU$302k	AU$275k	-AU$6m
Mar 31 2020	n/a	n/a	-AU$5m
Dec 31 2019	n/a	n/a	-AU$4m
Sep 30 2019	n/a	n/a	-AU$4m
Jun 30 2019	AU$306k	AU$250k	-AU$4m

Tazminat ve Piyasa: James's total compensation ($USD232.24K) is about average for companies of similar size in the Australian market ($USD299.27K).

Tazminat ve Kazançlar: James's compensation has been consistent with company performance over the past year.

CEO

James Bonnar

no data

Görev süresi

AU$354,285

Tazminat

Mr. James Bonnar has been Chief Executive Officer of Nyrada Inc. Mr. Bonnar had been Vice-President of R&D at Nyrada Inc. since February 2018. He joined Nyrada in February 2018, bringing over 20 years of e...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
John Moore	Non-Executive Chairman	5.4yrs	AU$129.05k	0.93% A$ 186.1k
Christopher Cox	Non-Executive Director	5yrs	AU$54.60k	0.78% A$ 156.7k
Marcus Frampton	Independent Non-Executive Director	5.4yrs	AU$54.60k	0.65% A$ 129.6k
Ian Dixon	Non-Executive Director	4.2yrs	AU$167.97k	5.7% A$ 1.1m
Rudiger Weseloh	Independent Non-Executive Director	5.4yrs	AU$49.64k	0.20% A$ 40.3k
Gisela Mautner	Non-Executive Director	2.3yrs	AU$57.03k	Veri yok
Gary Housley	Chairman of Scientific Advisory Board	no data	Veri yok	0.77% A$ 155.3k
Junichi Nabekura	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
David Burke	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Gilles Lambert	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Jim Palmer	Member of Scientific Advisory Board	no data	Veri yok	Veri yok

5.2yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: NYR's board of directors are considered experienced (5.2 years average tenure).

Nyrada Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Nyrada Inc., Annual General Meeting, Nov 12, 2024

Shareholders Will Probably Not Have Any Issues With Nyrada Inc.'s (ASX:NYR) CEO Compensation

Nyrada Inc., Annual General Meeting, Nov 20, 2023

Less than half of directors are independent

Nyrada Inc., Annual General Meeting, Nov 21, 2022

Nyrada Inc. Announces Board Changes

Recent updates

Nyrada Inc. has completed a Follow-on Equity Offering in the amount of AUD 3.359999 million.

Nyrada Inc., Annual General Meeting, Nov 12, 2024

Full year 2024 earnings released: AU$0.008 loss per share (vs AU$0.05 loss in FY 2023)

New major risk - Share price stability

New major risk - Market cap size

Nyrada Inc. has filed a Follow-on Equity Offering in the amount of AUD 1.965 million.

First half 2024 earnings released: EPS: AU$0.001 (vs AU$0.017 loss in 1H 2023)

Shareholders Will Probably Not Have Any Issues With Nyrada Inc.'s (ASX:NYR) CEO Compensation

Full year 2023 earnings released: AU$0.05 loss per share (vs AU$0.025 loss in FY 2022)

New minor risk - Financial data availability

New major risk - Share price stability

First half 2023 earnings released: AU$0.017 loss per share (vs AU$0.018 loss in 1H 2022)

Nyrada Inc., Annual General Meeting, Nov 20, 2023

Nyrada Inc. Provides Update on the Progress of Its Brain Injury Program

Less than half of directors are independent

Nyrada Inc., Annual General Meeting, Nov 21, 2022

Nyrada Inc. Announces Efficacy Study Published in Journal of Lipid Research

Full year 2022 earnings released: AU$0.03 loss per share (vs AU$0.03 loss in FY 2021)

Nyrada Inc. Announces Board Changes

Nyrada Inc. Provides Cholesterol-Lowering Program Update

Nyrada Inc. Unveils Target of Its Brain Injury Program as TRPC Ion Channels & Provides Phase I Study Update

European Patent to be Granted for Cholesterol-Lowering Drug of Nyrada Inc

Less than half of directors are independent

Nyrada Inc. Announces Its Newest Brain Injury Drug Candidate

Nyrada Inc. Announces Its Newest Brain Injury Drug Candidate

Companies Like Nyrada (ASX:NYR) Can Afford To Invest In Growth

Nyrada Inc Provides an Update on the Progress of its Brain Injury Program

Nyrada Inc Announces Encouraging Efficacy Results from Its in Vivo Study of NYX-PCSK9i Called called APOE*3-Leiden.CETP

Nyrada Inc Announces New Potent Cholesterol-Lowering Candidates

Nyrada Inc. announced that it expects to receive AUD 11 million in funding

We're Keeping An Eye On Nyrada's (ASX:NYR) Cash Burn Rate

Nyrada Inc. Releases Update on the Company's Two Drug Development Programs

Nyrada Inc. Secures Collaboration with Walter Reed Army Institute of Research and UNSW

Nyrada Reports Further Results from Cholesterol Study

New 90-day high: AU$0.45

New 90-day high: AU$0.28

New 90-day high: AU$0.23

Full year earnings released - AU$0.095 loss per share

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi